Mayo, Akeela N.

HRN: 27-56-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2025
CEFUROXIME 750MG (VIAL)
08/01/2025
08/08/2025
IV
750mg
Every 8hours
PCAP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: